Financial News · Live Terminal

Coreweave Insider Sold Shares Worth $47,541,261, According to a Recent SEC Filing

Brian M Venturo, Director, Chief Strategy Officer, on May 04, 2026, sold 375,000 shares in Coreweave (CRWV) for $47,541,261. Following the Form 4 filing with the SEC, Venturo has control over a total of 411,446 Class A common shares of the company, with 223,580 shares held directly and 187,866 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1769628/000176962826000215/xslF345X05/form4.xml

$CRWV

Ultra Clean Holdings Insider Sold Shares Worth $848,922, According to a Recent SEC Filing

Christopher S Cook, President of Products Division, on May 04, 2026, sold 11,478 shares in Ultra Clean Holdings (UCTT) for $848,922. Following the Form 4 filing with the SEC, Cook has control over a total of 101,527 common shares of the company, with 97,427 shares held directly and 4,100 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1275014/000095010326006917/xslF345X05/ownership.xml

$UCTT

Monolithic Power Systems Insider Sold Shares Worth $2,434,283, According to a Recent SEC Filing

Jeff Zhou, Director, on May 05, 2026, sold 1,514 shares in Monolithic Power Systems (MPWR) for $2,434,283. Following the Form 4 filing with the SEC, Zhou has control over a total of 4,286 common shares of the company, with 4,286 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1280452/000121465926005690/xslF345X05/marketforms-73065.xml

$MPWR

Travere Therapeutics Insider Sold Shares Worth $360,000, According to a Recent SEC Filing

Jeffrey A Meckler, Director, on May 04, 2026, sold 8,000 shares in Travere Therapeutics (TVTX) for $360,000. Following the Form 4 filing with the SEC, Meckler has control over a total of 87,500 common shares of the company, with 87,500 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000150691626000001/xslF345X05/form4-05062026_080516.xml

Travere Therapeutics Insider Sold Shares Worth $1,092,657, According to a Recent SEC Filing

Elizabeth E Reed, Chief Legal Officer and General Counsel, on May 04, 2026, sold 24,250 shares in Travere Therapeutics (TVTX) for $1,092,657. Following the Form 4 filing with the SEC, Reed has control over a total of 105,211 common shares of the company, with 105,211 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000128330326000009/xslF345X05/form4-05062026_080511.xml

Travere Therapeutics Insider Sold Shares Worth $1,015,086, According to a Recent SEC Filing

Jula Inrig, Chief Medical Officer, on May 04, 2026, sold 22,485 shares in Travere Therapeutics (TVTX) for $1,015,086. Following the Form 4 filing with the SEC, Inrig has control over a total of 113,238 common shares of the company, with 113,238 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000190236826000006/xslF345X05/form4-05062026_080509.xml

Travere Therapeutics Insider Sold Shares Worth $988,875, According to a Recent SEC Filing

Eric M Dube, Director and Chief Executive Officer, on May 04, 2026, sold 22,500 shares in Travere Therapeutics (TVTX) for $988,875. Following the Form 4 filing with the SEC, Dube has control over a total of 432,886 common shares of the company, with 432,886 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1438533/000176349426000006/xslF345X05/form4-05062026_080504.xml

Tko Group Holdings Insider Sold Shares Worth $1,770,287, According to a Recent SEC Filing

Nick Khan, Director, on May 04, 2026, sold 9,518 shares in Tko Group Holdings (TKO) for $1,770,287. Following the Form 4 filing with the SEC, Khan has control over a total of 91,100 Class A common shares of the company, with 91,100 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1973266/000119312526209747/xslF345X05/ownership.xml

$TKO

Figs Insider Sold Shares Worth $338,237, According to a Recent SEC Filing

Sarah Oughtred, Chief Financial Officer, on May 04, 2026, sold 23,597 shares in Figs (FIGS) for $338,237. Following the Form 4 filing with the SEC, Oughtred has control over a total of 1,129,791 Class A common shares of the company, with 1,129,791 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1846576/000162828026031588/xslF345X05/wk-form4_1778113091.xml

$FIGS

East West Bancorp Insider Sold Shares Worth $3,759,221, According to a Recent SEC Filing

Dominic Ng, Director, Chief Executive Officer, on May 06, 2026, sold 30,000 shares in East West Bancorp (EWBC) for $3,759,221. Following the Form 4 filing with the SEC, Ng has control over a total of 715,706 common shares of the company, with 707,930 shares held directly and 7,776 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1069157/000120123626000012/xslF345X05/wk-form4_1778113075.xml

$EWBC

Figs Insider Sold Shares Worth $464,203, According to a Recent SEC Filing

Heather L. Hasson, 10% Owner, Director, Executive Chairman, on May 04, 2026, sold 32,385 shares in Figs (FIGS) for $464,203. Following the Form 4 filing with the SEC, Hasson has control over a total of 1,442,286 Class A common shares of the company, with 1,433,807 shares held directly and 8,479 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1846576/000162828026031586/xslF345X05/wk-form4_1778112985.xml

$FIGS

Maplight Therapeutics Insider Sold Shares Worth $1,024,719, According to a Recent SEC Filing

Vishwas Setia, Chief Financial Officer, on May 04, 2026, sold 36,371 shares in Maplight Therapeutics (MPLT) for $1,024,719. Following the Form 4 filing with the SEC, Setia has control over a total of 356,256 voting common shares of the company, with 356,256 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202125626000008/xslF345X05/form4-05062026_080509.xml

Maplight Therapeutics Insider Sold Shares Worth $1,427,594, According to a Recent SEC Filing

Erin Pennock Foff, Chief Medical Officer, on May 04, 2026, sold 50,280 shares in Maplight Therapeutics (MPLT) for $1,427,594. Following the Form 4 filing with the SEC, Foff has control over a total of 350,497 voting common shares of the company, with 350,497 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000202123326000008/xslF345X05/form4-05062026_080507.xml

Maplight Therapeutics Insider Sold Shares Worth $1,468,251, According to a Recent SEC Filing

James Woodruff Lillie, Chief Scientific Officer, on May 04, 2026, sold 51,707 shares in Maplight Therapeutics (MPLT) for $1,468,251. Following the Form 4 filing with the SEC, Lillie has control over a total of 243,450 voting common shares of the company, with 243,450 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000172874626000008/xslF345X05/form4-05062026_080505.xml

Maplight Therapeutics Insider Sold Shares Worth $388,177, According to a Recent SEC Filing

Kristopher Hanson, General Counsel, on May 04, 2026, sold 13,917 shares in Maplight Therapeutics (MPLT) for $388,177. Following the Form 4 filing with the SEC, Hanson has control over a total of 176,248 voting common shares of the company, with 176,248 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000178997026000008/xslF345X05/form4-05062026_080503.xml

Maplight Therapeutics Insider Sold Shares Worth $1,412,236, According to a Recent SEC Filing

Christopher A. Kroeger, Director, Chief Executive Officer, on May 04, 2026, sold 49,744 shares in Maplight Therapeutics (MPLT) for $1,412,236. Following the Form 4 filing with the SEC, Kroeger has control over a total of 1,682,010 voting common shares of the company, with 1,580,820 shares held directly and 101,190 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1770069/000165891826000008/xslF345X05/form4-05062026_080501.xml

A10 Networks Insider Sold Shares Worth $672,033, According to a Recent SEC Filing

Eric Singer, Director, on May 05, 2026, sold 24,698 shares in A10 Networks (ATEN) for $672,033. Following the Form 4 filing with the SEC, Singer has control over a total of 68,806 common shares of the company, with 68,806 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1580808/000144328426000005/xslF345X05/wk-form4_1778117560.xml

$ATEN

Telix Pharmaceuticals Insider Bought Shares Worth $996,738, According to a Recent SEC Filing

Christian Behrenbruch, Managing Director and Group Chief Executive Officer, on April 28, 2026, executed a purchase for 67,935 shares in Telix Pharmaceuticals (TLX) for $996,738. Following the Form 4 filing with the SEC, Behrenbruch has control over a total of 20,742,935 ordinary shares of the company, with 20,742,935 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2007191/000162828026031608/xslF345X05/wk-form4_1778117523.xml

$TLX